Hyunju Liu
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Proteasome inhibition by bortezomib induces stress-response-mediated cytotoxicity in uterine leiomyosarcoma cells.
Journal: Biochemical and biophysical research communications
Published: January 21, 2026
TAK-981 enhances antitumor activity in ELT3 uterine leiomyoma cells through the modulation of apoptosis, cell cycle arrest, and autophagy.
Journal: Biochemical and biophysical research communications
Published: February 03, 2025
MG132 induces cell type‑specific anticancer effects in uterine leiomyosarcoma cell lines.
Journal: Molecular medicine reports
Published: January 10, 2025
Proteasome inhibitor MG132 modulates signal transduction pathways in ELT3 uterine leiomyoma cells.
Journal: Experimental and therapeutic medicine
Published: October 17, 2024
Ginkgolic acid regulates myogenic development by influencing the proliferation and differentiation of C2C12 myoblast cells.
Journal: Molecular medicine reports
Published: June 02, 2024
2-D08 treatment regulates C2C12 myoblast proliferation and differentiation via the Erk1/2 and proteasome signaling pathways.
Journal: Journal of muscle research and cell motility
Published: March 16, 2021
Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines.
Journal: Obstetrics & gynecology science
Published: March 16, 2019
Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice.
Journal: Obstetrics & gynecology science
Published: January 09, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026